Literature DB >> 30529086

Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates.

Heather Bradley1, Keri N Althoff2, Kate Buchacz3, John T Brooks3, M John Gill4, Michael A Horberg5, Mari M Kitahata6, Vincent Marconi7, Kenneth H Mayer8, Angel Mayor9, Richard Moore10, Michael Mugavero11, Sonia Napravnik12, Gabriela Paz-Bailey3, Joseph Prejean3, Peter F Rebeiro13, Christopher T Rentsch14, R Luke Shouse3, Michael J Silverberg15, Patrick S Sullivan16, Jennifer E Thorne2, Baligh Yehia10, Eli S Rosenberg17.   

Abstract

PURPOSE: To assess sampling bias in national viral suppression (VS) estimates derived from the Medical Monitoring Project (MMP) resulting from use of an abbreviated (four-month) annual sampling period. We aimed to improve VS estimates using cohort data from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) and a novel cohort-adjustment method.
METHODS: Using full calendar years of NA-ACCORD data, we assessed timing of HIV care attendance (inside vs. exclusively outside MMP's four-month sampling period), VS status at last test (<200 vs. ≥200 copies/mL), and associated demographics. These external estimates were used to standardize MMP to NA-ACCORD data with multivariable regression models of care attendance and VS, yielding adjusted 2009-2013 VS estimates with 95% confidence intervals.
RESULTS: Weighted percentages of VS among persons in HIV care were 67% in 2009 and 77% in 2013. These estimates are slightly lower than previously published MMP estimates (72% and 80% in 2009 and 2013, respectively). The number of persons receiving HIV care was previously underestimated by 20%, because patients receiving care exclusively outside the MMP sampling period did not contribute toward the weighted population estimate.
CONCLUSIONS: Careful examination of national surveillance estimates using data triangulation and novel methodologies can improve the robustness of VS estimates. Published by Elsevier Inc.

Entities:  

Keywords:  HIV clinical care; HIV viral suppression; Indirect standardization; Surveillance

Mesh:

Substances:

Year:  2018        PMID: 30529086      PMCID: PMC6420358          DOI: 10.1016/j.annepidem.2018.11.005

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  10 in total

1.  Time to first annual HIV care visit and associated factors for patients in care for HIV infection in 10 US cities.

Authors:  Patrick S Sullivan; Marta Juhasz; A D McNaghten; Martin Frankel; Sam Bozzette; Martin Shapiro
Journal:  AIDS Care       Date:  2011-06-14

2.  Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Authors:  Stephen J Gange; Mari M Kitahata; Michael S Saag; David R Bangsberg; Ronald J Bosch; John T Brooks; Liviana Calzavara; Steven G Deeks; Joseph J Eron; Kelly A Gebo; M John Gill; David W Haas; Robert S Hogg; Michael A Horberg; Lisa P Jacobson; Amy C Justice; Gregory D Kirk; Marina B Klein; Jeffrey N Martin; Rosemary G McKaig; Benigno Rodriguez; Sean B Rourke; Timothy R Sterling; Aimee M Freeman; Richard D Moore
Journal:  Int J Epidemiol       Date:  2007-01-08       Impact factor: 7.196

3.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

4.  Measuring retention in HIV care: the elusive gold standard.

Authors:  Michael J Mugavero; Andrew O Westfall; Anne Zinski; Jessica Davila; Mari-Lynn Drainoni; Lytt I Gardner; Jeanne C Keruly; Faye Malitz; Gary Marks; Lisa Metsch; Tracey E Wilson; Thomas P Giordano
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

5.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

6.  Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection.

Authors:  Heather Bradley; Christine L Mattson; Linda Beer; Ping Huang; R Luke Shouse
Journal:  AIDS       Date:  2016-08-24       Impact factor: 4.177

7.  Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.

Authors:  Janet M Blair; Jennifer L Fagan; Emma L Frazier; Ann Do; Heather Bradley; Eduardo E Valverde; Ad McNaghten; Linda Beer; Shuyan Zhang; Ping Huang; Christine L Mattson; Mark S Freedman; Christopher H Johnson; Catherine C Sanders; Kathryn E Spruit-McGoff; James D Heffelfinger; Jacek Skarbinski
Journal:  MMWR Suppl       Date:  2014-06-20

8.  Improving Estimation of HIV Viral Suppression in the United States: A Method to Adjust HIV Surveillance Estimates From the Medical Monitoring Project Using Cohort Data.

Authors:  Eli S Rosenberg; Heather Bradley; Kate Buchacz; Jennie McKenney; Gabriela Paz-Bailey; Joseph Prejean; John T Brooks; Luke Shouse; Patrick S Sullivan
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

9.  Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Jan van Lunzen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; David Asboe; Pompeyo Viciana; Félix Gutiérrez; Bonaventura Clotet; Christian Pradier; Jan Gerstoft; Rainer Weber; Katarina Westling; Gilles Wandeler; Jan M Prins; Armin Rieger; Marcel Stoeckle; Tim Kümmerle; Teresa Bini; Adriana Ammassari; Richard Gilson; Ivanka Krznaric; Matti Ristola; Robert Zangerle; Pia Handberg; Antonio Antela; Sris Allan; Andrew N Phillips; Jens Lundgren
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

10.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  10 in total
  2 in total

1.  HIV Risk and Prevention Outcomes in a Probability-Based Sample of Gay and Bisexual Men in the United States.

Authors:  Brian Dodge; Jessie V Ford; Na Bo; Wanzhu Tu; John Pachankis; Debby Herbenick; Kenneth Mayer; Mark L Hatzenbuehler
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731

2.  HIV and the liver.

Authors:  Kenneth E Sherman; Marion G Peters; David L Thomas
Journal:  Top Antivir Med       Date:  2019-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.